22NW, LP - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 13, 2026, for the 2025 Q4 period, 22NW, LP held in its portfolio 20 assets valued at $237,584,464 (i.e. $237.58M).

The most valuable assets in the portfolio included: ANEBULO PHARMACEUTICALS INC ($84.76M), FOSTER L B CO ($32.10M), and LIFECORE BIOMEDICAL INC ($23.03M).

The chart below shows the top 10 valuable assets, and the table below shows the top 20 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.

Data Source: SEC.

Top Valuable Stocks in 22NW, LP Portfolio

ANEBULO PHARMACEUTICALS INC

FOSTER L B CO

LIFECORE BIOMEDICAL INC

NEKTAR THERAPEUTICS

REGENXBIO INC

MINERALYS THERAPEUTICS INC

STONERIDGE INC

MAYVILLE ENGR CO INC

CULP INC

PHENIXFIN CORP

22NW, LP - Stock Holdings in 13F Filings (SEC)

Items per page:

0 of 0

Name of Issuer	No. of Shares	Value ($)	Class
ANEBULO PHARMACEUTICALS INC	15467300	84760804	COM
FOSTER L B CO	1191046	32098690	COM
LIFECORE BIOMEDICAL INC	1254	23026213	COM
NEKTAR THERAPEUTICS	331115	13999542	COM NEW
REGENXBIO INC	923679	13300978	COM
MINERALYS THERAPEUTICS INC	358325	13003614	COM
STONERIDGE INC	2192764	12696104	COM
MAYVILLE ENGR CO INC	414280	7755322	COM
CULP INC	1859061	6618257	COM
PHENIXFIN CORP	117885	5208159	COM
MEIRAGTX HLDGS PLC	586519	4662826	COM
CORE MOLDING TECHNOLOGIES	222738	4465897	COM
INSPERITY INC	96300	3728736	COM
UNIFI INC	852455	2983593	COM NEW
FARMER BROS CO	1955526	2855068	COM
TEAM INC	170187	2404742	COM NEW
REZOLUTE INC	820653	1936741	COM NEW
ELEDON PHARMACEUTICALS INC	636364	960910	COM
STRATA SKIN SCIENCES INC	536995	676614	COM
PSYCHEMEDICS CORPORATION CMN	276034	441654	COM